Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

NCT03326245 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Normal Physiology

Interventions

DRUG: Methylphenidate Pill
DRUG: Oral Placebo
DRUG: Intravenous Placebo
DRUG: Intravenous methylphenidate

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)